EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns

Xiao-He Hou, Wei Zhang, Kairan Kang, Yifei Jin, Peng Ren, Linbo Wang, Zeyu Li, Yuzhu Li, Jia You, Bei Zhang, Qing Ma, Alzheimer's Disease Neuroimaging Initiative und 4 weitere

Alzheimer's & Dementia · 2026

DOI: 10.1002/alz.71106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Xiao-He Hou und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Proteomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Noncommunicable Chronic Diseases-National Science and Technology Major Project, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) shows marked molecular heterogeneity. Defining biological subtypes may refine diagnosis and treatment. METHODS We analyzed cerebrospinal fluid (CSF) proteomics and longitudinal data from 550 participants in the Alzheimer's Disease Neuroimaging Initiative with up to 16.5 years of follow‐up. We profiled 6361 proteins, applied machine learning to identify biological subtypes, and validated them in three independent cohorts. RESULTS Three AD subtypes were identified. Subtype 1, enriched in RNA metabolism pathways, showed the mildest atrophy and slowest cognitive decline. Subtype 2, characterized by axonogenesis‐related pathways, exhibited the greatest CSF tau elevations, moderate atrophy, and intermediate decline. Subtype 3, associated with catabolic processes, showed the most severe atrophy and fastest progression. These patterns were consistently replicated across validation cohorts. DISCUSSION These findings demonstrate robust, biologically distinct AD subtypes linked to divergent molecular pathways, clinical features, and progression rates. Such refined stratification supports precision diagnostics and targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseProteomicsHumansDisease ProgressionFemaleMaleAgedtau ProteinsBiomarkersLongitudinal StudiesAtrophy

Stichwörter der Autor:innen

Alzheimer's diseasebiological subtypescerebrospinal fluidproteomics

Substanzen

tau ProteinsBiomarkers

Autor:innen und Institutionen

  • Department of Neurology, Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
  • Institute of Science and Technology for Brain-Inspired Intelligence, Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China.
  • State Key Laboratory of Brain Function and Disorders and MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China.
  • Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Ministry of Education, Shanghai, China.
  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • School of Data Science, Fudan University, Shanghai, China.

ORCID-Profile: Wei Cheng

Förderung

  • National Key R&D Program of China
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project
  • National Natural Science Foundation of China
  • Shanghai Pilot Program for Basic Research-Fudan University 21TQ1400100
  • Shanghai Science and Technology Commission Program
  • Science and Technology Innovation 2030 Major Projects
  • Research Start-Up Fund of Huashan Hospital
  • Excellence 2025 Talent Cultivation Program at Fudan University

Zitieren

APA

Hou, X. H., Zhang, W., Kang, K., Jin, Y., Ren, P., Wang, L., Li, Z., Li, Y., You, J., Zhang, B., Ma, Q., Alzheimer's Disease Neuroimaging Initiative, Xie, F., Yu, J. T., Feng, J. F., & Cheng, W. (2026). Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71106

Vancouver

Hou XH, Zhang W, Kang K, Jin Y, Ren P, Wang L, et al. Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71106

BibTeX
@article{Hou2026,
  author = {Hou, Xiao-He and Zhang, Wei and Kang, Kairan and Jin, Yifei and Ren, Peng and Wang, Linbo and Li, Zeyu and Li, Yuzhu and You, Jia and Zhang, Bei and Ma, Qing and Alzheimer's Disease Neuroimaging Initiative, Alzheimer's Disease Neuroimaging Initiative and Xie, Fang and Yu, Jin-Tai and Feng, Jian-Feng and Cheng, Wei},
  title = {Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns},
  journal = {Alzheimer's & Dementia},
  year = {2026},
  doi = {10.1002/alz.71106}
}
Kostenlos starten →